Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-12-05
2010-12-28
Lucas, Zachariah (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S005000, C435S007100, C530S387100, C530S388300
Reexamination Certificate
active
07858752
ABSTRACT:
Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5308750 (1994-05-01), Mehta et al.
patent: 5595868 (1997-01-01), Habets et al.
patent: 5753430 (1998-05-01), Mehta et al.
patent: 6015662 (2000-01-01), Hackett, Jr. et al.
patent: 6030792 (2000-02-01), Otterness et al.
patent: 6054264 (2000-04-01), Chien et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6727092 (2004-04-01), Shah et al.
patent: 7049060 (2006-05-01), Bahl
patent: 7091324 (2006-08-01), Foung et al.
patent: 2003/0148333 (2003-08-01), Bahl
patent: 2003/0152948 (2003-08-01), Shah et al.
patent: 2004/0110226 (2004-06-01), Lazar et al.
patent: 2004/0208887 (2004-10-01), Drakenberg et al.
patent: 2004/0214994 (2004-10-01), Burioni et al.
patent: 1881064 (2008-01-01), None
patent: WO 2006/037604 (2006-04-01), None
Ménez et al.,“Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D61,” Journal of Immunology, vol. 170 No. 4, pp. 1917-1924 (Feb. 2003).
Jolivet-Reynaud et al., “HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection,” Journal of Medical Virology, vol. 56 No. 4, pp. 300-309 (Dec. 1998).
Rudikoff et al., “Single amino acid substitution altering antigen-binding specificity,” Proceedings of the National Academy of Sciences, USA, vol. 79, pp. 1979-1983 (Mar. 1982).
Altschul, et al., J. Mol. Biol., 215, 403-410 (1990).
Barbas, et al., Proc. Natl. Acad. Sci. USA, 89, 4457-4461 (1992).
Brodeur, et al., Monoclonal Antibody Production Techniques and Application, Marcel Dekker, Inc., New York, 51-63 (1987).
Chao, et al., J. Mol. Biol., 342, 539-550, (2004).
Clackson, et al., Nature, 352, 624-628 (1991).
Courouce, et al., Transfusion, 40, 1198-1202 (2000).
Dou, et al., Journal of Clinical Microbiology, 40(1), 61-67 (2002).
Galfre, et al., Nature, 266, 550-552, (1977).
Goding, Monoclonal Antibodies: Principles and Practice, Academic Press, 59-103 (1986).
Hackett, Jr., et al., Journal of Clinical Microbiology,36(5), 1177-1284 (1998).
Johnson, et al., Current Opinion in Structural Biology, 3, 564-571 (1993).
Kozbor, et al., Journal of Immunology, 133(6), 3001-3005 (1984).
Hamilton, Ann. Biol., Clin. 48, 473-477(1990).
Hamilton, Ann. Biol. Clin. 49, 242-248 (1991).
Kohler, et al., Nature, 256, 495-497 (1975).
Li, et al., Journal of General Virology, 86, 1709-1716 (2005).
Marks, et al., J. Mol. Biol. 222, 581-597 (1991).
Miller, et al., Proc. Natl. Acad. Sci. USA, 87, 2057-2061 (1990).
Morrison, et al., Proc. Natl. Acad. Sci. USA, 81, 6851-6855 (1984).
Munson, et al., Analytical Biochemistry, 107, 220-239 (1980).
Naess, et al., Journal of Immunological Methods, 196, 41-49 (1996).
Neville, et al., Journal of Clinical Microbiology, 35(12), 3062-3070 (1997).
Schuurman, et al., J Allergy Clin Immunol, 99, 545-550 (1997).
Schwartz, et al., Atlas of Protein Sequence and Structure, 353-358 (1978).
Smith, et al., Advances in Applied Mathematics, 2, 482-489 (1981).
Smith, et al., J Clin Pathol 57, 912-917 (2004).
Smith, et al., J. Mol. Biol. 147, 195-197 (1981).
Wands, et al, Gastroenterology, 80, (2), 225-232 (1981).
Weiner, et al., Virology, 108, 842-848 (1991).
International Search Report for application No. PCT/US2007/86516, Mailed on Sep. 17, 2008, 7 pages.
Khudyakov, et al., “Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides”, Virology, 1995, 206(1), 666-672.
Masalova, et al., “Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus”, Immunology letters, 2002, 83 (3), 187-96.
Gutierrez Robin A.
Hawksworth David J.
Pinkus Mary S.
Scheffel James W.
Tu Bailin
Abbott Laboratories
Bartnicki Audrey L.
Lucas Zachariah
LandOfFree
Recombinant antibodies against hepatitis C virus and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant antibodies against hepatitis C virus and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant antibodies against hepatitis C virus and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177034